|
2024
|
Invention
|
E.coli mediated sepsis. The present invention relates to the field of in vitro prognosis of neona... |
|
2023
|
Invention
|
An implantable artificial heart. Present disclosure discloses an implantable total artificial hea... |
|
|
Invention
|
Immunotherapeutic compositions and adjuvants. The present invention provides compositions for mod... |
|
|
Invention
|
Method of estimating relaxation time from gradient echo magnetic resonance images. The invention ... |
|
|
Invention
|
Antigens for detection of early lyme disease. B. afzeliiB. afzelii. Advantageously, these antigen... |
|
|
Invention
|
Antisense nucleic acids for use in the treatment for lmna mutation carriers. The invention relate... |
|
|
Invention
|
Antisense nucleic acids for use in the treatment for kcnq1 mutation carriers. The invention relat... |
|
|
Invention
|
Small-molecule inhibitors targeting the bob1/oct1 interface. The present invention relates to com... |
|
|
Invention
|
Entospletinib for use in the treatment of covid19 patients. The invention relates to entospletini... |
|
2022
|
Invention
|
Prevention or treatment of hepatic steatosis. Anaerobutyricum soehngeniiAnaerobutyricum soehngeni... |
|
|
Invention
|
Bcma as a target for t cell redirecting antibodies in b cell lymphomas. Provided are methods for ... |
|
|
Invention
|
Wnt agonists for prevention of cancer. There is provided a Wnt agonist for use in preventing gast... |
|
|
Invention
|
Injectable cushioning hydrogels. The invention relates to a kit of parts, consisting of compositi... |
|
2021
|
Invention
|
Method for determining intra-tumor heterogeneity/copy number heterogeneity of a tumor in a patien... |
|
|
Invention
|
Method for determining copy number heterogeneity. Provided is for a method for determining copy n... |
|
|
Invention
|
Artificial heart muscle. VPvarvar V = Vcc V = Vee > Vcc VV. |
|
|
Invention
|
Fecal matter for treatment of cachexia. The present invention relates to the use of allogenic fec... |
|
|
Invention
|
Neutralizing antibodies binding to the spike protein of sars-cov-2 suitable for use in the treatm... |
|
|
Invention
|
Neuromodulation device.
The invention provides devices, apparatuses, systems and methods for tre... |
|
|
Invention
|
Intervention strategy for prevention or treatment of diabetes mellitus, autoimmune disease, infla... |
|
2020
|
Invention
|
Method for determining the risk of a thromboembolic event. The invention relates to a method of d... |
|
|
Invention
|
Combination therapy of alk-positive neoplasia.
The invention relates to a pharmaceutical product... |
|
|
Invention
|
Combination therapy of alk-positive neoplasia. The invention relates to a pharmaceutical product ... |
|
|
Invention
|
Ventilation perfusion protector. Embodiments of the present invention provide an ancillary device... |
|
2019
|
Invention
|
Stroma-targeting treatment for patients with elevated adam12 levels.
The invention relates to a ... |
|
|
Invention
|
Oncotherapeutic combinations. An oncotherapeutic product useful for the treatment of cancer. In a... |
|
|
Invention
|
Fecal matter for prevention or treatment of autoimmune diseases. The present invention relates to... |
|
2018
|
Invention
|
Composition for the treatment of intracellular bacterial infection. A method of treating or preve... |
|
|
Invention
|
Composition for the treatment of intracellular bacterial infection. The present invention provide... |
|
|
Invention
|
Improved hiv envelope glycoprotein immunogens. The invention relates to an isolated, recombinant ... |
|
|
Invention
|
Inhibitors of bmp2 and bmp4 signalling for use in the treatment of barrett's esophagus. The inven... |
|
|
Invention
|
A screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabol... |
|
|
Invention
|
Molecular biomarker for prognosis of sepsis patients. The invention relates to a method for deter... |
|
2017
|
Invention
|
Single-chip optical coherence tomography device. A high-performance single-chip, integrated-optic... |
|
|
Invention
|
Method of treating hepatitis b.
The present invention provides means and methods for determining... |
|
|
Invention
|
Biomarkers for determining the presence of an unstable atherosclerotic plaque. The invention rela... |
|
|
Invention
|
Method for determining the risk of developing arthritis.
The invention provides a method of dete... |
|
|
Invention
|
Method for determining the risk of developing arthritis. The invention provides a method of deter... |
|
|
Invention
|
Hepatic cell line resistant to dimethyl sulfoxide, cell culture and uses thereof.
The present in... |
|
|
Invention
|
Hepatic cell line resistant to dimethyl sulfoxide, cell culture and uses thereof. The present inv... |
|
2016
|
Invention
|
Device and method for determination of the moment-induced movement of a joint implant. The presen... |
|
|
Invention
|
Biomarker for risk stratification in cardiovascular disease. The invention relates to a miRNA tha... |
|
|
Invention
|
Flow cytometry method for determination of size and refractive index of substantially spherical s... |
|
|
Invention
|
Biomarker for predicting coronary artery disease in smokers. The invention relates to a method fo... |
|
|
Invention
|
Dried blood sample analysis. A non-destructive method of estimating hematocrit (Hct) of whole blo... |
|
|
Invention
|
Stabilized env proteins of hiv. The invention relates to an isolated, recombinant or synthetic po... |
|
|
Invention
|
Common-path integrated low coherence interferometry system and method therefor. A low coherence i... |
|
|
Invention
|
Neuromodulation device. The invention provides devices, apparatuses, systems and methods for trea... |
|
2015
|
Invention
|
Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method ... |
